Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2006-06-15
2009-11-03
Helms, Larry R. (Department: 1642)
Chemistry: molecular biology and microbiology
Vector, per se
C536S023100, C536S024300
Reexamination Certificate
active
07611892
ABSTRACT:
The invention provides novel STAMP2 nucleic acid molecules, polypeptides, antibodies, and modulatory compounds for use in methods of diagnosing, treating, and preventing diseases and conditions of the prostate and testis, such as cancer.
REFERENCES:
patent: 5599686 (1997-02-01), DeFeo-Jones et al.
patent: 5820880 (1998-10-01), Alving et al.
patent: 6048970 (2000-04-01), Lal et al.
patent: 6261562 (2001-07-01), Xu et al.
patent: 6277972 (2001-08-01), Afar et al.
patent: 6329503 (2001-12-01), Afar et al.
patent: 6509458 (2003-01-01), Afar et al.
patent: 6833438 (2004-12-01), Afar et al.
patent: 6887660 (2005-05-01), Xu et al.
patent: 6887975 (2005-05-01), Afar et al.
patent: 7053186 (2006-05-01), Afar et al.
patent: 7189565 (2007-03-01), Saatcioglu
patent: 2002/0187472 (2002-12-01), Lal et al.
patent: 2003/0064397 (2003-04-01), Spancake et al.
patent: 2004/0014087 (2004-01-01), Hodgson et al.
patent: 2004/0137455 (2004-07-01), Dong et al.
patent: 2005/0106643 (2005-05-01), Saatcioglu
patent: 0936270 (1999-08-01), None
patent: WO 98/37418 (1998-08-01), None
patent: WO 99/62941 (1999-12-01), None
patent: WO 99/62941 (1999-12-01), None
patent: WO 99/67384 (1999-12-01), None
patent: WO 00/04149 (2000-01-01), None
patent: WO 00/73509 (2000-12-01), None
patent: WO 00/75298 (2000-12-01), None
patent: WO 01/05970 (2001-01-01), None
patent: WO 01/11032 (2001-02-01), None
patent: WO 01/40276 (2001-06-01), None
patent: WO 01/72962 (2001-10-01), None
patent: WO 02/077243 (2002-10-01), None
patent: WO 03/009814 (2003-02-01), None
patent: WO 2005/114216 (2005-12-01), None
Boehringer Mannheim Biochemicals, 1994 Catalog, p. 93.
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,”Science247:1306-1310 (1990).
Brennen et al., “Cytokine Production in Culture by Cells Isolated from the Synovial Membrane,”J. Autoimm.2 suppl.:177-186 (1989).
Burgess et al., “Possible Dissociation of the Heparin-Binding and Mitogenic Activities of Heparin-Binding (Acidic Fibroblast) Growth Factor-1 from Its Receptor-Binding Activities by Site-Directed Mutagenesis of a Single Lysine Residue,”J. Cell Biol.111:2129-2138 (1990).
Conner et al., “Trk Receptor Alterations in Alzheimer's Disease,”Mol. Brain Res.42:1-17 (1996).
De Plaen et al., “Structure, Chromosomal Localization, and Expression of 12 Genes of the MAGE Family,”Immunogenetics40:360-369 (1994).
Deppenmeier et al., “Redox-Driven Proton Translocation in Methanogenic Archaea,”Cell. Mol. Life Sci.59:1513-1533 (2002).
Dias et al., “Shotgun Sequencing of the Human Transcriptome with ORF Expressed Sequence Tags,”Database EMBL Online! Database Asccession No. AI908168 [XP002279053] (1999).
Diatchenko et al., “Suppression Subtractive Hybridization: A Method for Generating Differentially Regulated or Tissue-Specific cDNA Probes and Libraries,”Proc. Nat. Acad. Sci. U.S.A.93:6025-6030 (1996).
Eriksson et al., “Insulin Resistance in Type 2 (Non-Insulin-Dependent) Diabetic Patients and Their Relatives is not Associated with a Defect in the Expression of the Insulin-Responsive Glucose Transporter (GLUT-4) Gene in Human Skeletal Muscle,”Diabetologia35:143-147 (1992).
Gillies and Wesolowski, “Antigen Binding and Biological Activities of Engineered Mutant Chimeric Antibodies with Human Tumor Specificities,”Human Antibod. Hybrid.1:47-54 (1990).
Isogai et al., “Homo sapienscDNA FLJ10829 fis, Clone NT2RP4001138,”Database EMBL Online! Database Accession No. AK001691 [XP002241852] (2000).
Korkmaz et al., “An Efficient Procedure for Cloning Hormone-Responsive Genes from a Specific Tissue,”DNA Cell Biol.19:499-506 (2000).
Korkmaz et al. “Molecular Cloning and Characterization of STAMP1, a Highly Prostate-Specific Six Transmembrane Protein that is Overexpressed in Prostate Cancer,”J. Biol. Chem.277:36689-36696 (2002).
Lazar et al., “Transforming Growth Factor α: Mutation of Aspartic Acid 47 and Leucine 48 Results in Different Biological Activities,”Mol. Cell. Biol.8:1247-1252 (1988).
Mahairas et al., “Sequence-Tagged Connectors: A Sequence Approach to Mapping and Scanning the Human Genome,”Proc. Nat. Acad. Sci. U.S.A.96:9739-9744 (1999).
Moldes et al., “Tumor Necrosis Factor-α-Induced Adipose-Related Protein (TIARP), a Cell-Surface Protein that is Highly Induced by Tumor Necrosis Factor-α and Adipose Conversion,”J. Biol. Chem.276:33938-33946 (2001).
MPSRCH Search Report for U.S. Appl. No. 10/239,607 a-23.oligo-500.rni, pp. 1-2 (2005).
MPSRCH Search Report for U.S. Appl. No. 10/239,607 a-23-copy-1510-1647.rnpb, pp. 2-4(2004).
MPSRCH Search Report for U.S. Appl. No. 10/239,607 a-14-copy-445-490.rapb, pp. 1-4 (2004).
Nelson et al., “Molecular Cloning and Characterization of Prostase, an Androgen-Regulated Serine Protease with Prostate-Restricted Expression,”Proc. Nat. Acad. Sci. U.S.A.96:3114-3119 (1999).
Passer et al., “The p53-Inducible TSAP6 Gene Product Regulates Apoptosis and the Cell Cycle and Interacts with Nix and the Myt1 Kinase,”Proc. Nat. Acad. Sci. U.S.A.100:2284-2289 (2003).
Phang, “The Regulatory Functions of Proline and Pyrroline-5-Carboxylic Acid,”Curr. Top. Cell. Regul.25:91-132 (1985).
Schmid et al., “Expression of AMPA Receptor Subunit Flip/Flop Splice Variants in the Rat Auditory Brainstem and Inferior Colliculus,”J. Comp. Neurol.430:160-171 (2001).
Steiner et al., “Growth Inhibition of Prostate Cancer by an Adenovirus Expressing a Novel Tumor Suppressor Gene, pHyde,”Cancer Res.60:4419-4425 (2000).
Stephenson et al., “Localization of a New Prostate-Specific Antigen-Related Serine Protease Gene, KLK4, is Evidence for an Expanded Human Kallikrein Gene Family Cluster on Chromosome 19q13.3-13.4,”J. Biol. Chem.274:23210-23214 (1999).
Tao and Morrison, “Studies of Aglycosylated Chimeric Mouse-Human IgG. Role of Carbohydrate in the Structure and Effector Functions Mediated by the Human IgG Constant Region,:”J. Immunol.143:2595-2601 (1989).
Ward, “Tumour Markers,” inImmunological Aspects of Cancer, Hancock and Ward (Eds.), Martimus Nijhoff Publishers, Boston, pp. 91-106 (1985).
Warkentin et al., “Structures of F420H2:NADP+Oxidoreductase With and Without Its Substrates Bound,”EMBO J.20:6561-6569 (2001).
Watanabe et al., “Protein Kinase N (PKN) and PKN-Related Protein Rhophilin as Targets of Small GTPase Rho,”Science271:645-648 (1996).
Yousef et al., “Prostase/KLK-L1 is a New Member of the Human Kallikrein Gene Family, is Expressed in Prostate and Breast Tissues, and is Hormonally Regulated,”Cancer Res.59:4252-4256 (1999).
Zimmer, “Examination of the Calcium-Modulated Protein S100α and Its Target Proteins in Adult and Developing Skeletal Muscle,”Cell Motil. Cytoskeleton20:325-337 (1991).
International Preliminary Examination Report for PCT/US01/09410 dated Jul. 28, 2002.
International Search Report for PCT/US01/09410 dated Sep. 6, 2001.
International Search Report for PCT/IB05/001357 dated Jan. 10, 2006.
International Search Report for PCT/IB00/00673 dated Oct. 26, 2000.
Supplementary European Search Report for EP 01922630 dated May 5, 2004.
Bieker-Brady Kristina
Clark & Elbing LLP
Davis Minh-Tam
Helms Larry R.
President and Fellows of Harvard College
LandOfFree
Prostate-specific or testis-specific nucleic acid molecules,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostate-specific or testis-specific nucleic acid molecules,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostate-specific or testis-specific nucleic acid molecules,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4054100